
Imdm Media
IMDM
IMDM (Iscove's Modified Dulbecco's Medium) is a cell culture medium used for the growth and maintenance of various mammalian cell types, including hematopoietic cells and hybridomas. It contains a mixture of amino acids, vitamins, and other nutrients, and can be supplemented with serum or other growth factors as needed for specific cell types.Description
Performance

IMDM (Iscove's Modified Dulbecco's Medium) is a cell culture medium that was originally developed for the growth of hematopoietic cells, but is now commonly used for the culture of a variety of mammalian cell types. The medium contains a balanced mixture of amino acids, vitamins, salts, and glucose, and is supplemented with fetal bovine serum (FBS) or other serum supplements to provide additional nutrients and growth factors for the cells.
IMDM is often used in biomedical research for a variety of applications, including the growth and maintenance of lymphoid and myeloid cell lines, the cultivation of primary cells from various tissues, and the production of hybridomas for monoclonal antibody production. The medium is also used for the differentiation of stem cells into hematopoietic lineages.
IMDM is named after its developer, Dr. Norman Iscove, and is a modification of the original Dulbecco's Modified Eagle Medium (DMEM). The medium is designed to support the growth and maintenance of a wide range of cell types, and can be modified or supplemented with other components depending on the specific requirements of the cells being cultured.
Order Information
IMDM
Serum-free Media
|
Product Name |
Cat. NO. |
Form |
Size |
NOTE |
Product Instruction(pdf) |
Product Formula(pdf) |
Inquiries /Sample application |
|
IMDM (Without α-thioglycerin, |
EXP0103105 |
Powder |
200 L |
With phenol red, L-glutamine, sodium pyruvate, HEPES; |
|||
| EXP0103102 |
Powder |
10 L |
|||||
| EXP0103103 |
Liquid |
1000 ml |
With phenol red, L-glutamine, sodium pyruvate, HEPES, sodium bicarbonate; |
||||
| EXP0103104 |
Liquid |
500 ml |
|
Cell Line |
Serum-Free Cell Culture Media |
NOTE |
|
CHO-K1, CHO-ZN, CHO-S, CHO DG44 and HORIZON |
Eden series CHO CD media |
Animal-derived component-free (ADCF), Protein-free/Peptide ingredients-free, Chemically Defined |
|
HEK293, 293T, and 293F cells |
Celer series HEK293 media |
Animal-derived component-free (ADCF), Serum-free and protein-free (SF and PF)
|
|
BHK |
Tac series BHK medium |
Animal-derived component-free (ADCF), Serum-free and protein-free (SF and PF) |
|
Sf9 and High five |
Vigor series insect cell media |
Animal-derived component-free (ADCF), Serum-free and protein-free (SF and PF) |
|
Vero |
Acgro CD Medium |
Chemically defined Animal-derived component-free (ADCF), Serum-free and protein-free (SF and PF) |
|
Hybridoma |
Hyber series hybridoma cell media |
Animal-derived component-free (ADCF), Serum-free and protein-free (SF and PF) |
|
PK15 |
Proli series PK15 cell media |
Animal-derived component-free (ADCF), Serum-free and protein-free (SF and PF) |
|
MDBK |
Bofit series MDBK media |
Animal-derived component-free (ADCF), Serum-free and protein-free (SF and PF) |
|
MDCK |
Xeno series MDCK media |
Animal-derived component-free (ADCF), Serum-free and protein-free (SF and PF) |
|
LMH |
Serum-Free media for LMH cells |
Animal-derived component-free (ADCF), Serum-free and protein-free (SF and PF) |
|
Vero, 293, ST, Marc145, PK15, and other adherent cells |
Low-Serum Medium for Adherent Cells |
Transfer from 10% serum condition without adaptation. |
|
T-cell, NK cell, CAR-T, CIK, CAR-NK, NK-92, NK-92MI, K562 ,Jurkat, etc. |
HIPP series Lymphocyte Media |
Manufactured under the cGMP guidelines and ISO13485 quality system, meet regulatory requirements in different countries |
FAQ
Q1:What is the difference between DMEM and IMDM media?
Q2:How long can I keep my media after supplementing with serum?
Q3:What are serum-free media?
Q4:What are BHK-21 cells?
Q5:What is the medium for hybridoma cells?
Q6:What media is used for culturing mammalian cells?
Q7:What is an MDBK cell?
Q8:What media is used for MDCK cells?
Q9:What does RPMI media stand for?
Previous
No InformationNext
No InformationHot Tags: imdm media, China imdm media manufacturers, suppliers, factory
Antibodies
In fed-batch process, CHO cells cultured in Eden CD CHO media demonstrate higher viable cell density (VCD) and protein production than competitors. On average, the antibody titers of various CHO cell lines cultured in Eden CD CHO media ranged from 2 to 11 g/L.

In the pulse perfusion process, CHO cells cultured in Eden CD CHO media demonstrated superior performance than competitive global brands. When VVD=1.0, volumetric productivity (Vp) can reach up to 2.2 g/L/day, and the cumulative product expression in 14 days can reach 19 g/L, 55% higher than global brand B. When VVD=2.0, Vp can reach up to 3.3g/L/day, and the cumulative product expression in 14 days can reach 25 g/L.

Brochures
| CHO Cell Medium |
FAQ
Q1: What is the packaging for BioEngine's powder media?
Q2: Can we seal the bag if there is leftover powdered medium?
Q3: What is the shelf life of BioEngine's Eden series CHO cell culture media, and how do you verify the expiration date?
Q4: Does BioEngine offer any regulators or additives for modulating antibody glycosylation?
Q5: Does BioEngine's CHO cell culture media contain hydrolysates, insulin, cytokines, or other components?
Q6: What are CHO media?
Q7: What are the differences between DMEM and RPMI?
1. Nutrient composition: DMEM (Dulbecco's Modified Eagle's Medium) and RPMI (Roswell Park Memorial Institute) have different nutrient compositions. DMEM contains higher levels of glucose, amino acids, vitamins, and sodium pyruvate, while RPMI has a lower glucose concentration and a different amino acid and vitamin composition.
2. pH: DMEM has a higher pH (7.4-7.6) compared to RPMI (7.2-7.4).
3. Usage: DMEM is a more general-purpose medium and can be used for a wide range of cell types, including adherent and non-adherent cells, while RPMI is typically used for the culture of immune cells such as lymphocytes and hybridomas.
4. Serum requirement: RPMI is often used with lower serum concentrations (e.g. 5-10%) than DMEM, which may require higher serum concentrations (e.g. 10-20%).
Overall, the choice between DMEM and RPMI depends on the specific cell type being cultured and the experimental conditions.
Q8: What is a fed-batch culture?
The goal of a fed-batch culture is to maximize cell growth and productivity while maintaining a stable culture environment. By controlling the rate and timing of nutrient addition, the culture can be kept in a state of controlled growth, avoiding the depletion of nutrients and accumulation of waste products that can limit growth and product formation in batch cultures. Additionally, the use of a fed-batch culture can allow for the accumulation of high cell densities and the optimization of production conditions, leading to higher yields and greater efficiency in bioprocesses.
Q9: What are the advantages of suspension cell cultures?
1. Scalability: Suspension cell cultures can be easily scaled up to produce large quantities of cells. This makes them particularly useful for biomanufacturing and the production of recombinant proteins.
2. Flexibility: Suspension cultures can be adapted to a wide range of culture conditions, such as pH, temperature, and nutrient availability. This allows for the optimization of cell growth and productivity.
3. Homogeneity: Suspension cultures provide a more homogeneous population of cells than adherent cultures, where cells may exhibit varying degrees of differentiation and proliferation.
4. Reduced risk of contamination: Suspension cultures are less prone to contamination by bacteria or fungi than adherent cultures, as there are no surfaces for microorganisms to adhere to.
5. Ease of harvesting: Cells in suspension culture can be easily harvested using centrifugation, filtration, or other methods. This simplifies downstream processing and reduces the risk of damage to the cells.
Overall, suspension cell culture offers several advantages over other types of cell culture, particularly in the context of large-scale biomanufacturing and the production of recombinant proteins.
Q10: What is gene therapy?
●Replacing a disease-causing gene with a healthy copy of the gene.
●Inactivating or deleting a disease-causing gene.
●Introducing a new or modified gene to help fight disease.
Gene therapy is a promising and innovative field of medicine that has potential applications for many diseases, such as cancer, genetic disorders, infectious diseases, and autoimmune diseases 23. However, gene therapy also faces many challenges and risks, such as safety, efficacy, ethical issues, and regulatory hurdles.
Gene therapy usually be delivered to the cells by virus vector, such as AAV, Adv and RV. BioEngine provides vigor series insect cell media for large scale AAV production."
Q11: Does BioEngine provides serum products, like FBS?
Previous
No InformationNext
Imdm PowderSend Inquiry
Provide high quality culture media for research institutions, biopharmaceutical companies and clinical trial institutions, etc.
I agree to receive other communications from BioEngine which may contain technical or marketing information from this organization. You can unsubscribe from these communications at any time.
By submitting this form, you are agreeing to the terms and conditions of our Privacy Policy
You Might Also Like







